Semaglutide has surged in popularity over the past two years, thanks to its remarkable effectiveness as a long-acting GLP-1 ...

After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic ...

Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent metabolic and bariatric surgery, according to study results published ...

Whether you’re talking to a partner, a friend, or your doctor, weight loss can be a sensitive topic. And if you’re thinking ...

In a real-world setting, the administration of oral semaglutide leads to a significant reduction in the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and albuminuria.

Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a maintenance fee in 2019.

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using GLP-1Rs such as Ozempic or Wegovy.

The emergency kits include medication to prevent HIV and other sexually transmitted infections, as well as unwanted pregnancies.

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.

There are several strategies to help you control your portion sizes and avoid mindless snacking. We’ve all been there. You ...